The Pacific Research Institute champions freedom,
opportunity, and personal responsibility for all
individuals by advancing free-market policy solutions.

SUPPORT PRI

JOIN SAFFS

YOUNG LEADERS CIRCLE

Latest

Study
PRI Comments on Pending Department of Labor Regulations on Proxy Measures, ESG
September 29, 2020
Wayne Winegarden
29 September, 2020

Study
PRI Comments on Pending Department of Labor Regulations on Proxy Measures, ESG
September 29, 2020
Wayne Winegarden
29 September, 2020
Commentary
TheStreet Profiles Dr. Henry Miller on FDA Woes
September 29, 2020
Pacific Research Institute
29 September, 2020
Commentary
Wayne Winegarden Featured in Newsweek Drug Pricing Story
September 29, 2020
Pacific Research Institute
29 September, 2020
Study
NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs
September 29, 2020
Wayne Winegarden
29 September, 2020
Commentary
Massive coverage losses are greatly exaggerated
September 29, 2020
Sally C. Pipes
29 September, 2020
Blog
Prop. 19 Could Be a Huge Tax Increase for Middle Class Californians Inheriting Homes
September 29, 2020
Tim Anaya
29 September, 2020
Commentary
Industry Voices—Surprise! There’s a better fix for surprise bills
September 28, 2020
Sally C. Pipes
28 September, 2020
Commentary
Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation
September 28, 2020
Sally C. Pipes
28 September, 2020
Commentary
Supreme Court and ObamaCare – here’s what to expect if law is not upheld
September 28, 2020
Sally C. Pipes
28 September, 2020
Commentary
How Trump can trounce Biden on healthcare
September 28, 2020
Sally C. Pipes
28 September, 2020
Blog
While California Wars Against Charter Schools, Harvard Finds Charter Performance Growth
September 28, 2020
Lance Izumi
28 September, 2020
Commentary
Gavin Newsom’s battery-powered virtue-signaling
September 26, 2020
Kerry Jackson
26 September, 2020

Latest

PRI Comments on Pending Department of Labor Regulations on Proxy Measures, ESG

PRI Comments on Pending Department of Labor Regulations on Proxy Measures, ESG

TheStreet Profiles Dr. Henry Miller on FDA Woes

Wayne Winegarden Featured in Newsweek Drug Pricing Story

NEW BRIEF: Mandating that Drug Rebates Benefit Consumers Will Help Patients with High Out-of-Pocket Drug Costs

Massive coverage losses are greatly exaggerated

Prop. 19 Could Be a Huge Tax Increase for Middle Class Californians Inheriting Homes

Industry Voices—Surprise! There’s a better fix for surprise bills

Cleveland Is Trump’s Best Chance To Reshape The Healthcare Conversation

Supreme Court and ObamaCare – here’s what to expect if law is not upheld

How Trump can trounce Biden on healthcare

While California Wars Against Charter Schools, Harvard Finds Charter Performance Growth

Gavin Newsom’s battery-powered virtue-signaling

A Conversation with Education Secretary Betsy DeVos

PRI’s 9th Annual Baroness Thatcher Dinner with Kimberley Strassel

DATE CHANGE – Winning the Water Wars

Prop. 19 Could Be a Huge Tax Increase for Middle Class Californians Inheriting Homes

While California Wars Against Charter Schools, Harvard Finds Charter Performance Growth

What We’re Watching – Remembering RBG

ABOUT PRI

RESEARCH AREAS

OUR WORK

Gallery